Šalis: Australija
kalba: anglų
Šaltinis: Department of Health (Therapeutic Goods Administration)
fluorouracil, Quantity: 500 mg
MedTAS Pty Ltd
Injection, solution
Excipient Ingredients: sodium hydroxide; water for injections
Intravenous
5 vials, 1 vial, 10 vials
(S4) Prescription Only Medicine
Alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,Fluorouracil should only be used when other proven measures have failed or are considered,impractical.
Visual Identification: A clear, colorless to yellow aqueous solution, free from visible particles.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Registered
2022-01-14